Internal Medicine, Pulmonary Disease · Warwick, RI
NPI
1245236918
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1050 Warwick Ave
Warwick, RI, 02888
Phone (401) 467-6210
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
1,752 services
Medicare patients, 2024
383
Average age 76
Drug cost, 2024
$1.6M
8,639 prescriptions
Company payments, 2025
$2,062
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas J Raimondo was code 99215 (office e&m - established), 493 times for 230 patients. In total Thomas J Raimondo billed 1,752 services in 34 codes, and Medicare paid $150K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 493 | 230 | $133.07 | $66K |
| 99214 Office E&M - Established | Office | 291 | 176 | $94.98 | $28K |
| 94727 Pulmonary Function Testing | Office | 191 | 191 | $34.33 | $6,558 |
| 94729 Pulmonary Function Testing | Office | 191 | 191 | $42.58 | $8,133 |
| 94010 Pulmonary Function Testing | Office | 179 | 179 | $21.03 | $3,764 |
| 99233 Hospital E&M - Subsequent | Facility | 94 | 43 | $92.38 | $8,684 |
| 99205 Office E&M - New | Office | 52 | 52 | $167.18 | $8,694 |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 27 | $60.78 | $2,735 |
| 99223 Hospital E&M - Initial | Facility | 45 | 45 | $129.94 | $5,847 |
| 99291 Critical Care E&M | Facility | 31 | 17 | $160.54 | $4,977 |
| 94618 Pulmonary Function Testing | Office | 27 | 27 | $25.64 | $692 |
| 99213 Office E&M - Established | Office | 19 | 17 | $71.64 | $1,361 |
| 99239 Hospital Discharge Management | Facility | 16 | 16 | $84.44 | $1,351 |
By year: 2022 $215K for 2,395 services; 2023 $173K for 2,004 services; 2024 $150K for 1,752 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas J Raimondo prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 653 prescriptions and refills. In total Thomas J Raimondo wrote 8,639 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 653 | 735 | 153 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 588 | 648 | 99 | $401K |
| Prednisone Generic | 348 | 467 | 129 | $2,685 |
| Azithromycin Generic | 347 | 537 | 86 | $7,523 |
| Montelukast Sodium Generic | 346 | 841 | 81 | $3,716 |
| Fluticasone Propionate Generic | 280 | 510 | 78 | $5,554 |
| Breo Ellipta Fluticasone/Vilanterol | 253 | 307 | 40 | $119K |
| Omeprazole Generic | 220 | 467 | 47 | $3,771 |
| Pantoprazole Sodium Generic | 216 | 522 | 61 | $2,399 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 145 | 165 | 28 | $13K |
| Furosemide Generic | 138 | 281 | 35 | $546 |
| Arnuity Ellipta Fluticasone Furoate | 138 | 162 | 25 | $39K |
| Ventolin Hfa Albuterol Sulfate | 135 | 151 | 41 | $9,184 |
| Cefuroxime Cefuroxime Axetil | 134 | 134 | 95 | $2,337 |
| Atorvastatin Calcium Generic | 132 | 310 | 29 | $2,106 |
Brand drugs: 2,702 claims; generic drugs: 5,912 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas J Raimondo $2,062 ($2,062 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $485.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 24 | $485 |
| GlaxoSmithKline, LLC. GSK | 19 | $345 |
| Genzyme Corporation SNY | 10 | $237 |
| Verona Pharma, Inc. VRNA | 8 | $155 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $129 |
| Pfizer Inc. PFE | 6 | $107 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $105 |
| Baxter Healthcare BAX | 4 | $90.92 |
| United Therapeutics Corporation UTHR | 4 | $87.98 |
| CSL Behring CSL.AX | 3 | $75.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.